Detalles de la búsqueda
1.
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study).
Cancer Immunol Immunother
; 72(1): 91-99, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35729418
2.
Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC 04-2017).
Future Oncol
; 16(4): 5-10, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31894704
3.
Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo).
Lung Cancer
; 178: 191-197, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36868180
4.
Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancer.
J Cancer Res Clin Oncol
; 149(16): 15095-15102, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37626173
5.
Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study).
J Immunother
; 2023 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37807621
6.
Awake prone positioning for hypoxaemic respiratory failure: past, COVID-19 and perspectives.
Eur Respir Rev
; 30(160)2021 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33952601
7.
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018.
J Thorac Oncol
; 15(4): 628-636, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31945494
8.
PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 "EPNEC" study.
Ther Adv Med Oncol
; 12: 1758835920937972, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32684990
9.
Pathogen inactivation: making decisions about new technologies. Report of a consensus conference.
Transfusion
; 47(12): 2338-47, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18036075
Resultados
1 -
9
de 9
1
Próxima >
>>